126 related items for PubMed ID: 38123128
1. A Novel Preoperative Score to Predict Long-Term Biochemical Remission in Patients with Growth-Hormone Secreting Pituitary Adenomas.
Cohen-Cohen S, Rindler R, Botello Hernandez E, Donegan D, Erickson D, Meyer FB, Atkinson JL, Van Gompel JJ.
World Neurosurg; 2024 Feb; 182():e882-e890. PubMed ID: 38123128
[Abstract] [Full Text] [Related]
2. Predictors of postoperative biochemical remission in lower Knosp grade growth hormone-secreting pituitary adenomas: a large single center study.
Zhang S, Chen J, Yao S, Akter F, Wang Z, Hu B, Zhu D, Duan C, Chen W, Zhu Y, Wang H, Mao Z.
J Endocrinol Invest; 2023 Mar; 46(3):465-476. PubMed ID: 36125731
[Abstract] [Full Text] [Related]
3. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
Taweesomboonyat C, Oearsakul T.
World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643
[Abstract] [Full Text] [Related]
4. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Cardinal T, Rutkowski MJ, Micko A, Shiroishi M, Jason Liu CS, Wrobel B, Carmichael J, Zada G.
Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
[Abstract] [Full Text] [Related]
5. Endoscopic Endonasal Approach to the Growth Hormone-Secreting Pituitary Adenomas: Endocrinologic Outcome in 68 Patients.
Taghvaei M, Sadrehosseini SM, Ardakani JB, Nakhjavani M, Zeinalizadeh M.
World Neurosurg; 2018 Sep; 117():e259-e268. PubMed ID: 29902603
[Abstract] [Full Text] [Related]
6. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas.
Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ.
Neurosurg Focus; 2010 Oct; 29(4):E5. PubMed ID: 20887130
[Abstract] [Full Text] [Related]
7. Giant growth hormone-secreting pituitary adenomas from the endocrinologist's perspective.
Koylu B, Firlatan B, Sendur SN, Oguz SH, Dagdelen S, Erbas T.
Endocrine; 2023 Mar; 79(3):545-553. PubMed ID: 36318446
[Abstract] [Full Text] [Related]
8. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.
Nishioka H, Fukuhara N, Horiguchi K, Yamada S.
J Neurosurg; 2014 Sep; 121(3):505-10. PubMed ID: 25014437
[Abstract] [Full Text] [Related]
9. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
Hofstetter CP, Mannaa RH, Mubita L, Anand VK, Kennedy JW, Dehdashti AR, Schwartz TH.
Neurosurg Focus; 2010 Oct; 29(4):E6. PubMed ID: 20887131
[Abstract] [Full Text] [Related]
10. Transsphenoidal surgery for acromegaly: predicting remission with early postoperative growth hormone assays.
Sarkar S, Jacob KS, Pratheesh R, Chacko AG.
Acta Neurochir (Wien); 2014 Jul; 156(7):1379-87; discussion 1387. PubMed ID: 24781680
[Abstract] [Full Text] [Related]
11. Efficacy of transsphenoidal surgery in achieving biochemical cure of growth hormone-secreting pituitary adenomas among patients with cavernous sinus invasion: a systematic review and meta-analysis.
Briceno V, Zaidi HA, Doucette JA, Onomichi KB, Alreshidi A, Mekary RA, Smith TR.
Neurol Res; 2017 May; 39(5):387-398. PubMed ID: 28301972
[Abstract] [Full Text] [Related]
12. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N.
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[Abstract] [Full Text] [Related]
13. Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission.
Starke RM, Raper DM, Payne SC, Vance ML, Oldfield EH, Jane JA.
J Clin Endocrinol Metab; 2013 Aug; 98(8):3190-8. PubMed ID: 23737543
[Abstract] [Full Text] [Related]
14. Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly.
Cardinal T, Collet C, Wedemeyer M, Singer PA, Weiss M, Zada G, Carmichael JD.
Front Endocrinol (Lausanne); 2021 Aug; 12():743052. PubMed ID: 34867787
[Abstract] [Full Text] [Related]
15. Transsphenoidal surgery for growth hormone-secreting pituitary adenomas in 130 patients.
Shirvani M, Motiei-Langroudi R.
World Neurosurg; 2014 Jan; 81(1):125-30. PubMed ID: 23313263
[Abstract] [Full Text] [Related]
16. Long-term control of acromegaly after pituitary surgery in South-Eastern Norway.
Falch CM, Dupont AK, Olarescu NC, Wiedmann M, Dahlberg D, Bollerslev J, Berg-Johnsen J, Heck A.
Acta Neurochir (Wien); 2023 Oct; 165(10):3003-3010. PubMed ID: 37665404
[Abstract] [Full Text] [Related]
17. Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: a study on 184 patients.
Lampropoulos KI, Samonis G, Nomikos P.
Hormones (Athens); 2013 Oct; 12(2):254-64. PubMed ID: 23933694
[Abstract] [Full Text] [Related]
18. Acromegaly without imaging evidence of pituitary adenoma.
Lonser RR, Kindzelski BA, Mehta GU, Jane JA, Oldfield EH.
J Clin Endocrinol Metab; 2010 Sep; 95(9):4192-6. PubMed ID: 20610592
[Abstract] [Full Text] [Related]
19. Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results.
Santoro A, Minniti G, Ruggeri A, Esposito V, Jaffrain-Rea ML, Delfini R.
Surg Neurol; 2007 Nov; 68(5):513-8; discussion 518. PubMed ID: 17961741
[Abstract] [Full Text] [Related]
20. SIGNIFICANT ELEVATION OF GROWTH HORMONE LEVEL IMPACTS SURGICAL OUTCOMES IN ACROMEGALY.
Anthony JR, Alwahab UA, Kanakiya NK, Pontell DM, Veledar E, Oyesiku NM, Ioachimescu AG.
Endocr Pract; 2015 Sep; 21(9):1001-9. PubMed ID: 26121434
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
